FDA Warns Exosome Maker for Marketing Outside Its IND
The FDA has warned Kimera Labs that it can’t sell its exosome product for uses outside of its recently secured investigational new drug (IND) application. In a warning letter that was posted to the FDA’s website last September, then removed, and then posted again this month, the agency also told the Miramar, Florida-based company that […]
Companies Market Stem Cell Treatments to Long COVID Patients
Clinics that sell stem cell and exosome treatments have turned their attention to long COVID patients, researchers found. Among 38 businesses selling such treatments for COVID-19, the majority (36) marketed those therapies for long COVID, stated Leigh Turner, PhD, of the University of California Irvine, and colleagues in Stem Cell Reports. “We didn’t think the […]